AzTrials
AzTrials

Lateral EpicondylitisNCT06869733

Scooping Mobilization With and Without Scapulothoracic Mobilization in Patients of Lateral Epicondylalgia

A study testing Scooping Mobilization and Scooping Mobilization with Scapulothoracic mobilization in people with Lateral Epicondylitis, run by Riphah International University at 2 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Lateral epicondylalgia is well known musculoskeletal disorder now a day. Lateral epicondylalgia is a disorder in which pain and tenderness at lateral part of elbow. This study is targeting the scapulothoracic mobilization and scooping mobilization at lateral epicondylalgia. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Lateral Epicondylitis
What is being tested?
Scooping Mobilization and Scooping Mobilization with Scapulothoracic mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
2 sitesPakistan
Study dates
2 May 2023to 2 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 20-40 years
  • Pain and tenderness around lateral epicondyle
  • Pain on resisted elbow extension ,wrist extension and gripping activities
  • Gender both male and female.
  • Scapular Dyskinesia.
  • Positive Cozen test and maudsley test for lateral epicondylalgia.
  • With moderate pain intensity on Numeric Pain Rating Scale (NPRS) with a score of 3 or higher

Who cannot join

  • Any injury or disease around the shoulder, elbow and wrist on affected side
  • Cervical radiculopathy.
  • Local steroid injection
  • History of fracture of humerus, radius, ulna which is affected upper extremity

Trial locations and contacts

2 sites in 1 country.

Pakistan2 sites
  • Dr. Humera Mubashar

    Lahore, Punjab Province, 53000

  • Dr. Faiza Amjad

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Official title: Effects of Scooping Mobilization With and Without Scapulothoracic Mobilization in Pain Range of Motion and Activities of Daily Living in Patients of Lateral Epicondylalgia

Lateral epicondylalgia is well known musculoskeletal disorder now a day. Lateral epicondylalgia is a disorder in which pain and tenderness at lateral part of elbow. This study is targeting the scapulothoracic mobilization and scooping mobilization at lateral epicondylalgia. This study is single-blinded Randomized Clinical Trial will be conducted in Fatima memorial Hospital and Bajwa hospital Lahore. Non-probability convenience sampling will be used with 38 Participants involved in this study is with age of 18 to 45 with presence of pain and tenderness around lateral epicondyle, positive Cozens test and maudsley test, scapular dyskinesia, pain on resisted elbow extension, wrist extension and gripping activities. In this study, one group is treated with scooping mobilization with scapulothoracic mobilization. Second group is treated with scooping mobilization alone. The participants will be randomized into two Groups by computer generated randomization software. Outcomes measures which are used in this study is Numeric pain rating scale for pain, goniometer for range of motion and patient related tennis elbow evaluation for activities of daily livings for patients of lateral epicondylalgia.

Being tested
Scooping Mobilization, Scooping Mobilization with Scapulothoracic mobilization
Keywords
Scooping mobilization, scapulothoracic mobilization, activities of daily livings, lateral epicondylalgia
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Scooping MobilizationOther

    Group A treated with only scooping mobilization with frequency of 2 to 3 times in a week for consecutive 4 weeks.

  • Scooping Mobilization with Scapulothoracic mobilizationOther

    Group B treated with scooping mobilization with scapulothoracic mobilization, which was given 2 to 3 times in a week for consecutive 4 weeks.

Study groups in NCT06869733
Study groupRoleWhat they receive
Scooping MobilizationActive comparatorGroup A treated with scooping mobilization only.
Receives: Other: Scooping Mobilization
Scooping Mobilization with Scapulothoracic mobilizationExperimentalGroup B treated with scooping mobilization with scapulothoracic mobilization.
Receives: Other: Scooping Mobilization with Scapulothoracic mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Related Tennis Elbow Evaluation Scale

    It consist of two subscales, one is pain and second is functional subscale (specific activities: 6 and usual activities . The pain scale is scored out of 50 by summing five items. The function subscale (six items) and usual function subscale (four items) are summed divided by two to create the Function Subscale. The pain score is added to the function score to determine the final score. A score of 100 indicates the highest level of commitment, while a score of 0 indicates no involvement at all..

    Measured: 4th weeks

  2. Numeric Pain Rating Scale

    It rates from 0 to 10. 0 means no pain while 10 means maximum pain.

    Measured: 4th weeks

  3. Range of Motion of Elbow

    Goniometer is to check ranges of elbow flexion and extension

    Measured: 4th weeks

  4. Range of Motion of Wrist

    Goniometer is to check ranges of wrist flexion and extension

    Measured: 4th weeks

  5. Readings of scapulometer to measure scapular dyskinesia in cm

    The medial boundary and inferior angle prominence in relation to the thorax can be measured with a Scapulometer. The minimal detectable change (MDC) was determined to be 1.2-1.3 mm.

    Measured: 4th weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2025
  2. Study start2 May 2023
  3. Primary completion23 Dec 2023
  4. Study completion2 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06869733
Sponsor's protocol ID
REC/RCR&AHS/24/0125
Status last verified
Mar 2025
First submitted
4 Mar 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Scooping Mobilization and Scooping Mobilization with Scapulothoracic mobilization in people with Lateral Epicondylitis, run by Riphah International University at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Related Tennis Elbow Evaluation Scale (time frame: 4th weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in